Updated
Eli Lilly and CompanyLLY · Healthcare
$1,411.82+4.27%
Market cap$1.33T
IndustryDrug Manufacturers - General
Eli Lilly and Company (LLY) Superinvestor holders
52 of the superinvestors we track hold Eli Lilly and Company (LLY) in their latest 13F filings, $34.4B in total.
Summary
The largest holder is PRIMECAP Management (PRIMECAP Management Co), with $11.0B, 6.5% of the portfolio.
In their latest quarter: 3 opened a new position, 24 added, 23 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| PRIMECAP Management PRIMECAP Management Co |
Trimmed | 9,172,904 | $11.0B | 6.5% | Q2 2026 |
| Jennison Associates | Added | 5,461,416 | $6.6B | 3.9% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 5,424,027 | $6.3B | 1.8% | Q3 2026 |
| Cliff Asness AQR Capital Management |
Added | 1,035,605 | $1.2B | 0.4% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 895,262 | $1.1B | 1.8% | Q2 2026 |
| Jeremy Grantham GMO |
Trimmed | 743,966 | $892M | 2.0% | Q2 2026 |
| Dan Davidowitz Polen Capital Management |
Trimmed | 666,912 | $800M | 6.9% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 520,536 | $602M | 0.7% | Q3 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 496,563 | $596M | 0.4% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Added | 483,528 | $580M | 0.5% | Q2 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Added | 425,688 | $511M | 1.2% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 398,861 | $478M | 0.9% | Q2 2026 |
| Alan Breed Edgewood Management |
Trimmed | 388,627 | $466M | 4.8% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 334,637 | $401M | 0.3% | Q2 2026 |
| Artisan Partners | Added | 328,382 | $394M | 0.6% | Q2 2026 |
| Mairs & Power Mairs & Power Inc |
Trimmed | 322,129 | $386M | 3.5% | Q2 2026 |
| Arrowstreet Capital | Trimmed | 249,935 | $300M | 0.1% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 176,517 | $212M | 0.5% | Q2 2026 |
| Jensen Investment Management | Trimmed | 153,735 | $184M | 4.5% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Added | 140,540 | $169M | 0.3% | Q2 2026 |
| Teewinot Capital Teewinot Capital Advisers |
Added | 131,992 | $158M | 11.5% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Added | 87,023 | $104M | 0.4% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 81,240 | $97M | 0.1% | Q2 2026 |
| Thornburg Thornburg Investment Management |
Added | 79,682 | $96M | 0.9% | Q2 2026 |
| Cathie Wood ARK Investment Management |
Added | 77,254 | $93M | 0.6% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 77,094 | $92M | 1.4% | Q2 2026 |
| Alger Fred Alger Management |
Trimmed | 75,669 | $91M | 0.3% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 72,685 | $87M | 0.2% | Q2 2026 |
| Larry Robbins Glenview Capital Management |
New position | 57,771 | $69M | 1.4% | Q2 2026 |
| David Vogel Voloridge Investment Management |
Trimmed | 56,499 | $68M | 0.3% | Q2 2026 |
| Frank Sands Sands Capital Management |
Added | 45,332 | $54M | 0.2% | Q2 2026 |
| Dodge & Cox | Trimmed | 41,258 | $49M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Trimmed | 30,885 | $37M | 0.2% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Added | 27,377 | $33M | 0.3% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 26,091 | $31M | 0.0% | Q2 2026 |
| George Soros Soros Fund Management |
Held | 22,199 | $27M | 0.4% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 21,971 | $26M | 0.1% | Q2 2026 |
| WCM Investment Management | Trimmed | 14,882 | $18M | 0.0% | Q2 2026 |
| Stanley Druckenmiller Duquesne Family Office |
New position | 12,380 | $15M | 0.3% | Q2 2026 |
| Eric Marshall Hodges Capital Management |
Added | 10,780 | $13M | 0.9% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 10,476 | $13M | 0.0% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Added | 5,956 | $7M | 0.0% | Q2 2026 |
| John Gardner Gardner Lewis Asset Management |
Trimmed | 4,878 | $6M | 1.3% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Added | 4,012 | $5M | 0.2% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Trimmed | 3,824 | $5M | 0.1% | Q2 2026 |
| Fred DiSanto Ancora Holdings |
Added | 3,182 | $4M | 0.1% | Q2 2026 |
| Rob Citrone Discovery Capital Management |
New position | 2,267 | $3M | 0.1% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
Added | 1,790 | $2M | 0.0% | Q2 2026 |
| Mark Donovan Boston Partners |
Added | 1,057 | $1M | 0.0% | Q2 2026 |
| Bill Nygren Harris Associates LP |
Trimmed | 431 | $516,954 | 0.0% | Q2 2026 |
| Robert Torray Torray Investment Partners |
Held | 398 | $460,518 | 0.1% | Q3 2026 |
| David Katz Matrix Asset Advisors |
Trimmed | 305 | $352,453 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 52 |
| Q1 2026 | 50 |
| Q4 2025 | 47 |
| Q3 2025 | 40 |
| Q2 2025 | 45 |
| Q1 2025 | 45 |
| Q4 2024 | 47 |
| Q3 2024 | 43 |
Questions about Eli Lilly and Company
Which superinvestors own Eli Lilly and Company?
52 of the superinvestors we track hold Eli Lilly and Company (LLY) in their latest 13F filings, $34.4B in total. PRIMECAP Management, Jennison Associates, Ken Fisher, Cliff Asness, Ensign Peak, Jeremy Grantham.
Who is the largest superinvestor holder of LLY?
The largest holder is PRIMECAP Management (PRIMECAP Management Co), with $11.0B, 6.5% of the portfolio.
From Eli Lilly and Company's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.